”With our cash balance growing it has become increasingly important for the business to review our capital requirements going forward. A significant review of our capital allocation framework was commenced in the second half with a view to defining the discipline and prioritisation of our financial parameters in a way that optimises and supports our long-term plan.”
Maybe we will get further details during the AGM?
- Forums
- ASX - By Stock
- A2M
- A2M FY20 Results
A2M FY20 Results, page-14
-
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.82 |
Change
-0.005(0.10%) |
Mkt cap ! $3.504B |
Open | High | Low | Value | Volume |
$4.80 | $4.87 | $4.79 | $8.665M | 1.788M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
38 | 20625 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.82 | 3327 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
38 | 20625 | 4.810 |
43 | 51872 | 4.800 |
15 | 40473 | 4.790 |
11 | 39462 | 4.780 |
7 | 111269 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.820 | 3327 | 8 |
4.830 | 7371 | 8 |
4.840 | 28506 | 12 |
4.850 | 55693 | 11 |
4.860 | 16006 | 8 |
Last trade - 14.59pm 13/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online